KR20220148883A - 세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 - Google Patents

세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 Download PDF

Info

Publication number
KR20220148883A
KR20220148883A KR1020227034047A KR20227034047A KR20220148883A KR 20220148883 A KR20220148883 A KR 20220148883A KR 1020227034047 A KR1020227034047 A KR 1020227034047A KR 20227034047 A KR20227034047 A KR 20227034047A KR 20220148883 A KR20220148883 A KR 20220148883A
Authority
KR
South Korea
Prior art keywords
gene
tissue repair
action
derived
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227034047A
Other languages
English (en)
Korean (ko)
Inventor
다카마사 이시도메
마사유키 야마네
Original Assignee
후지필름 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지필름 가부시키가이샤 filed Critical 후지필름 가부시키가이샤
Publication of KR20220148883A publication Critical patent/KR20220148883A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020227034047A 2020-03-31 2021-03-19 세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법 Pending KR20220148883A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020065052 2020-03-31
JPJP-P-2020-065052 2020-03-31
PCT/JP2021/011546 WO2021200299A1 (ja) 2020-03-31 2021-03-19 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法

Publications (1)

Publication Number Publication Date
KR20220148883A true KR20220148883A (ko) 2022-11-07

Family

ID=77928040

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227034047A Pending KR20220148883A (ko) 2020-03-31 2021-03-19 세포 노화 억제제, 생체 조직 수복 촉진제, 유전자 발현 조절제 및 제조 방법

Country Status (3)

Country Link
JP (1) JP7478227B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220148883A (cg-RX-API-DMAC7.html)
WO (1) WO2021200299A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7371975B1 (ja) * 2022-09-27 2023-10-31 セルソース株式会社 細胞外小胞の製造方法及び細胞外小胞含有組成物
JP7433685B1 (ja) 2023-06-09 2024-02-20 日生バイオ株式会社 真皮線維芽細胞の機能賦活用剤及びそれを含んでなる化粧品

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088689A1 (ja) 2014-12-05 2016-06-09 和光純薬工業株式会社 Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108392494A (zh) 2018-05-15 2018-08-14 江苏大学 人脐带间质干细胞分泌的exosome在制备修复皮肤紫外线损伤的药物中的应用
CN109172859A (zh) * 2018-09-06 2019-01-11 上海长海医院 人干细胞来源外泌体复合外源性透明质酸在制备皮肤创面缺损修复药物或材料中的应用
CN110548001A (zh) * 2019-09-06 2019-12-10 沈阳细胞治疗工程技术研发中心有限公司 一种含脐带间充质干细胞外泌体的修复抗衰护肤品

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088689A1 (ja) 2014-12-05 2016-06-09 和光純薬工業株式会社 Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
비특허문헌 1: Mathieu M, Martin-Jaular L, Lavieu G, Thery C(2019) Nat Cell Biol, 21(1):9-17
비특허문헌 2: Arsalan S et al. STEM CELLS AND DEVELOPMENT Volume 24, Number 14, 2015
비특허문헌 3: Bocheng Zhang et al. Cell Transplantation Volume 29:1-14
비특허문헌 4: Connie S. Chamberlain al. Stem Cells. 2021; 39:55-61.

Also Published As

Publication number Publication date
JP7478227B2 (ja) 2024-05-02
WO2021200299A1 (ja) 2021-10-07
JPWO2021200299A1 (cg-RX-API-DMAC7.html) 2021-10-07

Similar Documents

Publication Publication Date Title
Takov et al. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential
EP3029061B1 (en) Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
Blaber et al. Analysis of in vitro secretion profiles from adipose-derived cell populations
KR101655780B1 (ko) 클로날 중간엽 줄기세포를 포함하는, 아토피성 피부염 예방 또는 치료용 약학적 조성물
KR102127527B1 (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
KR20220024060A (ko) 질환 치료용 엑소좀
KR20200083596A (ko) 엑소좀을 단리시키기 위한 태반의 배양
HK1256111A1 (zh) 干细胞衍生的含有大量生长因子的外来体
JP7449590B2 (ja) 間葉系幹細胞由来のエキソソーム生産方法およびこれから製造された培養液
Hamid et al. Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: role of PDGF signaling
EP3515459A1 (en) Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
ES2914692T3 (es) Células madre adhesivas derivadas de cordón umbilical mejoradas, método de preparación para las mismas, y uso de las mismas
US20220362290A1 (en) Anti-fibrosis agent and method of producing extracellular vesicle having anti-fibrosis action
US20230220423A1 (en) Extracellular Vesicles Engineered to Be Loaded with Distinct RNA Cargo for Improved Therapeutic Efficacy
KR20190003399A (ko) 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부 섬유증 개선 용도
CN115397445A (zh) 包含来源于凝血酶处理的干细胞的外泌体的用于预防或治疗糖尿病性皮肤病的组合物
JP7478227B2 (ja) 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法
Jiao et al. Stimulation of mouse hair regrowth by exosomes derived from human umbilical cord mesenchymal stem cells
Kim et al. Canine amniotic membrane-derived mesenchymal stem cells ameliorate atopic dermatitis through regeneration and immunomodulation
JP2024520415A (ja) 線維芽細胞及び線維芽細胞由来産物を用いる脱毛症治療のための方法及び組成物
Kong et al. The crosstalk among macrophages, chondrocytes and mesenchymal stem cells in osteoarthritis: the role of extracellular vesicles
Tilotta et al. Wharton's Jelly Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Attenuate Intervertebral Disc Degeneration Under Inflammatory Stress in an In Vitro 3D Culture System
KR20250090208A (ko) 혼합 엑소좀을 유효성분으로 포함하는 조성물 및 이의 용도
EP3903793A1 (en) Pharmaceutical composition comprising clonal stem cell for prevention or treatment of atopic dermatitis
US20230126684A1 (en) Anti-inflammatory agent and method of producing extracellular vesicle having anti-inflammatory action

Legal Events

Date Code Title Description
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000